Dorian Therapeutics, Inc. is a pioneering biotech company based in San Carlos, CA, dedicated to addressing the challenges of aging and age-associated diseases. With a focus on the biology of aging, Dorian is at the forefront of developing senoblockers, a groundbreaking class of therapeutics that rejuvenate cells and tissues, offering innovative solutions for unmet medical needs.
By leveraging a patented technology developed at Stanford University, Dorian's team is actively working towards reversing the decline in stem cell activity and eliminating the accumulation of senescent cells in the body. Through the targeted action of their Senoblockers on epigenetic regulators, Dorian aims to reactivate programs of youthfulness and regeneration, enabling individuals to live younger, healthier lives for longer.
Generated from the website